Baidu
map

JCO:口服阿扎胞苷对低风险骨髓增生异常综合征患者的影响

2021-03-29 宁咸襄 MedSci原创

Journal of Clinical Oncology近日发表了一篇研究。结果显示,CC-486虽然可以增加LR-MDS患者不依赖红细胞输血比例,但可能会增加患者早死风险。

近日,Journal of Clinical Oncology在线发表了一篇研究,研究显示,CC-486虽然可以增加LR-MDS患者不依赖红细胞输血比例,但可能会增加患者早死风险。

论文封面截图

骨髓增生异常综合症(MDS)涵盖了一组以骨髓异常增生和外周血细胞减少症为特征的血液系统疾病。国际预后评分系统(IPSS)根据细胞遗传学特征,血细胞减少症的数量和胚细胞百分比将患者分为四个风险组:低风险和中风险-1型被认为是较低风险的MDS(LR-MDS),而中风险-2型和高风险被认为是较高风险的MDS。

该实验于2013年4月至2018年2月在20个国家/地区的101个地点招募了患者,研究一共纳入216例LR-MDS患者,患者入组后按照1:1比例被随机分入CC-486组(107例)和安慰剂组(109例),两组患者分别接受300mgCC-486/安慰剂治疗,21天/28天为一个治疗周期。

技术路线


入组患者中位血小板计数为25×109/L。在CC-486组和安慰剂组中,分别有31%和11%的患者接受了非红细胞依赖输注治疗(RBC-TI)(P=0.0002),两组的中位持续治疗时间分别为11.1个月和5个月。相比基线,CC-486组血红蛋白升高≥1.5g/dL的患者比例更高(23.4%vs 4.6%),血液学的改善情况亦更好(24.3%vs 6.5%)。虽然两组的总死亡率相似,但是在研究开始的56天内,CC-486组患者死亡率更高(16例vs 6例),大多数死亡原因为中性粒细胞减少导致感染


虽然CC-486可以增加具备高风险临床特征的LR-MDS患者的RBC-TI治疗比例并改善此类患者血液学情况,但在CC-486组中更多的患者出现因中性粒细胞减少导致感染的早死情况。

这些结果表明,CC-486可以在具有症状性疾病和难治性血细胞减少症的LR-MDS患者中减少RBC的输血负担并改善血小板减少症,但是CC-486组的早期死亡发生率较高,这与治疗前中性粒细胞减少症患者的感染密切相关。正在进行的分子和HRQoL分析可能为这些临床结果提供更多背景。有必要对MDS患者进行CC-486的进一步评估,这可能有助于确定可能从该疗法中受益的患者。

 

参考文献:

Garcia-Manero G, Santini V, Almeida A, Platzbecker U, Jonasova A, Silverman LR, Falantes J, Reda G, Buccisano F, Fenaux P, Buckstein R, Diez Campelo M, Larsen S, Valcarcel D, Vyas P, Giai V, Olíva EN, Shortt J, Niederwieser D, Mittelman M, Fianchi L, La Torre I, Zhong J, Laille E, Lopes de Menezes D, Skikne B, Beach CL, Giagounidis A. Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes. J Clin Oncol. 2021 Mar 25:JCO2002619. doi: 10.1200/JCO.20.02619. Epub ahead of print. PMID: 33764805.

https://ascopubs.org/doi/10.1200/JCO.20.02619?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1242693, encodeId=8c19124269310, content=口服<a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a>对低风险<a href='/topic/show?id=fab3101964cd' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合征#</a>患者的影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97818, encryptionId=96129e81891, topicName=阿扎胞苷), TopicDto(id=101964, encryptionId=fab3101964cd, topicName=骨髓增生异常综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Fri Sep 02 03:06:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004236, encodeId=24462004236f8, content=<a href='/topic/show?id=4bac10196249' target=_blank style='color:#2F92EE;'>#骨髓增生异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101962, encryptionId=4bac10196249, topicName=骨髓增生异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Mon Nov 22 08:51:49 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821922, encodeId=7d0b1821922fe, content=<a href='/topic/show?id=7db310196345' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101963, encryptionId=7db310196345, topicName=骨髓增生异常综合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Oct 19 04:51:49 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821814, encodeId=8e951821814ee, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101961, encryptionId=d1ba10196122, topicName=骨髓增生)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Tue Nov 02 17:51:49 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891641, encodeId=33c5189164124, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Sep 14 23:51:49 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432032, encodeId=9931143203265, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 31 13:51:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952235, encodeId=b6c7952235ed, content=认真, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Tue Mar 30 08:18:03 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952183, encodeId=af0595218382, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Mar 29 23:01:49 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2022-09-02 小小医者

    口服#阿扎胞苷#对低风险#骨髓增生异常综合征#患者的影响

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1242693, encodeId=8c19124269310, content=口服<a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a>对低风险<a href='/topic/show?id=fab3101964cd' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合征#</a>患者的影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97818, encryptionId=96129e81891, topicName=阿扎胞苷), TopicDto(id=101964, encryptionId=fab3101964cd, topicName=骨髓增生异常综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Fri Sep 02 03:06:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004236, encodeId=24462004236f8, content=<a href='/topic/show?id=4bac10196249' target=_blank style='color:#2F92EE;'>#骨髓增生异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101962, encryptionId=4bac10196249, topicName=骨髓增生异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Mon Nov 22 08:51:49 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821922, encodeId=7d0b1821922fe, content=<a href='/topic/show?id=7db310196345' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101963, encryptionId=7db310196345, topicName=骨髓增生异常综合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Oct 19 04:51:49 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821814, encodeId=8e951821814ee, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101961, encryptionId=d1ba10196122, topicName=骨髓增生)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Tue Nov 02 17:51:49 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891641, encodeId=33c5189164124, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Sep 14 23:51:49 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432032, encodeId=9931143203265, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 31 13:51:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952235, encodeId=b6c7952235ed, content=认真, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Tue Mar 30 08:18:03 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952183, encodeId=af0595218382, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Mar 29 23:01:49 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1242693, encodeId=8c19124269310, content=口服<a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a>对低风险<a href='/topic/show?id=fab3101964cd' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合征#</a>患者的影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97818, encryptionId=96129e81891, topicName=阿扎胞苷), TopicDto(id=101964, encryptionId=fab3101964cd, topicName=骨髓增生异常综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Fri Sep 02 03:06:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004236, encodeId=24462004236f8, content=<a href='/topic/show?id=4bac10196249' target=_blank style='color:#2F92EE;'>#骨髓增生异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101962, encryptionId=4bac10196249, topicName=骨髓增生异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Mon Nov 22 08:51:49 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821922, encodeId=7d0b1821922fe, content=<a href='/topic/show?id=7db310196345' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101963, encryptionId=7db310196345, topicName=骨髓增生异常综合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Oct 19 04:51:49 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821814, encodeId=8e951821814ee, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101961, encryptionId=d1ba10196122, topicName=骨髓增生)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Tue Nov 02 17:51:49 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891641, encodeId=33c5189164124, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Sep 14 23:51:49 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432032, encodeId=9931143203265, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 31 13:51:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952235, encodeId=b6c7952235ed, content=认真, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Tue Mar 30 08:18:03 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952183, encodeId=af0595218382, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Mar 29 23:01:49 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1242693, encodeId=8c19124269310, content=口服<a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a>对低风险<a href='/topic/show?id=fab3101964cd' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合征#</a>患者的影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97818, encryptionId=96129e81891, topicName=阿扎胞苷), TopicDto(id=101964, encryptionId=fab3101964cd, topicName=骨髓增生异常综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Fri Sep 02 03:06:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004236, encodeId=24462004236f8, content=<a href='/topic/show?id=4bac10196249' target=_blank style='color:#2F92EE;'>#骨髓增生异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101962, encryptionId=4bac10196249, topicName=骨髓增生异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Mon Nov 22 08:51:49 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821922, encodeId=7d0b1821922fe, content=<a href='/topic/show?id=7db310196345' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101963, encryptionId=7db310196345, topicName=骨髓增生异常综合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Oct 19 04:51:49 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821814, encodeId=8e951821814ee, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101961, encryptionId=d1ba10196122, topicName=骨髓增生)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Tue Nov 02 17:51:49 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891641, encodeId=33c5189164124, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Sep 14 23:51:49 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432032, encodeId=9931143203265, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 31 13:51:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952235, encodeId=b6c7952235ed, content=认真, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Tue Mar 30 08:18:03 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952183, encodeId=af0595218382, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Mar 29 23:01:49 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1242693, encodeId=8c19124269310, content=口服<a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a>对低风险<a href='/topic/show?id=fab3101964cd' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合征#</a>患者的影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97818, encryptionId=96129e81891, topicName=阿扎胞苷), TopicDto(id=101964, encryptionId=fab3101964cd, topicName=骨髓增生异常综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Fri Sep 02 03:06:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004236, encodeId=24462004236f8, content=<a href='/topic/show?id=4bac10196249' target=_blank style='color:#2F92EE;'>#骨髓增生异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101962, encryptionId=4bac10196249, topicName=骨髓增生异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Mon Nov 22 08:51:49 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821922, encodeId=7d0b1821922fe, content=<a href='/topic/show?id=7db310196345' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101963, encryptionId=7db310196345, topicName=骨髓增生异常综合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Oct 19 04:51:49 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821814, encodeId=8e951821814ee, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101961, encryptionId=d1ba10196122, topicName=骨髓增生)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Tue Nov 02 17:51:49 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891641, encodeId=33c5189164124, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Sep 14 23:51:49 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432032, encodeId=9931143203265, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 31 13:51:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952235, encodeId=b6c7952235ed, content=认真, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Tue Mar 30 08:18:03 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952183, encodeId=af0595218382, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Mar 29 23:01:49 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-09-14 lidong40
  6. [GetPortalCommentsPageByObjectIdResponse(id=1242693, encodeId=8c19124269310, content=口服<a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a>对低风险<a href='/topic/show?id=fab3101964cd' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合征#</a>患者的影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97818, encryptionId=96129e81891, topicName=阿扎胞苷), TopicDto(id=101964, encryptionId=fab3101964cd, topicName=骨髓增生异常综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Fri Sep 02 03:06:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004236, encodeId=24462004236f8, content=<a href='/topic/show?id=4bac10196249' target=_blank style='color:#2F92EE;'>#骨髓增生异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101962, encryptionId=4bac10196249, topicName=骨髓增生异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Mon Nov 22 08:51:49 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821922, encodeId=7d0b1821922fe, content=<a href='/topic/show?id=7db310196345' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101963, encryptionId=7db310196345, topicName=骨髓增生异常综合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Oct 19 04:51:49 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821814, encodeId=8e951821814ee, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101961, encryptionId=d1ba10196122, topicName=骨髓增生)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Tue Nov 02 17:51:49 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891641, encodeId=33c5189164124, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Sep 14 23:51:49 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432032, encodeId=9931143203265, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 31 13:51:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952235, encodeId=b6c7952235ed, content=认真, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Tue Mar 30 08:18:03 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952183, encodeId=af0595218382, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Mar 29 23:01:49 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-31 zhouqu_8
  7. [GetPortalCommentsPageByObjectIdResponse(id=1242693, encodeId=8c19124269310, content=口服<a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a>对低风险<a href='/topic/show?id=fab3101964cd' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合征#</a>患者的影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97818, encryptionId=96129e81891, topicName=阿扎胞苷), TopicDto(id=101964, encryptionId=fab3101964cd, topicName=骨髓增生异常综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Fri Sep 02 03:06:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004236, encodeId=24462004236f8, content=<a href='/topic/show?id=4bac10196249' target=_blank style='color:#2F92EE;'>#骨髓增生异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101962, encryptionId=4bac10196249, topicName=骨髓增生异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Mon Nov 22 08:51:49 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821922, encodeId=7d0b1821922fe, content=<a href='/topic/show?id=7db310196345' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101963, encryptionId=7db310196345, topicName=骨髓增生异常综合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Oct 19 04:51:49 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821814, encodeId=8e951821814ee, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101961, encryptionId=d1ba10196122, topicName=骨髓增生)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Tue Nov 02 17:51:49 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891641, encodeId=33c5189164124, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Sep 14 23:51:49 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432032, encodeId=9931143203265, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 31 13:51:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952235, encodeId=b6c7952235ed, content=认真, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Tue Mar 30 08:18:03 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952183, encodeId=af0595218382, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Mar 29 23:01:49 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-30 carrotlyl

    认真

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1242693, encodeId=8c19124269310, content=口服<a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a>对低风险<a href='/topic/show?id=fab3101964cd' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合征#</a>患者的影响, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97818, encryptionId=96129e81891, topicName=阿扎胞苷), TopicDto(id=101964, encryptionId=fab3101964cd, topicName=骨髓增生异常综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Fri Sep 02 03:06:27 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2004236, encodeId=24462004236f8, content=<a href='/topic/show?id=4bac10196249' target=_blank style='color:#2F92EE;'>#骨髓增生异常#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101962, encryptionId=4bac10196249, topicName=骨髓增生异常)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Mon Nov 22 08:51:49 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821922, encodeId=7d0b1821922fe, content=<a href='/topic/show?id=7db310196345' target=_blank style='color:#2F92EE;'>#骨髓增生异常综合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101963, encryptionId=7db310196345, topicName=骨髓增生异常综合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Tue Oct 19 04:51:49 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1821814, encodeId=8e951821814ee, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101961, encryptionId=d1ba10196122, topicName=骨髓增生)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Tue Nov 02 17:51:49 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1891641, encodeId=33c5189164124, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10272, encryptionId=25b0102e2df, topicName=JCO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6da1120, createdName=lidong40, createdTime=Tue Sep 14 23:51:49 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432032, encodeId=9931143203265, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed Mar 31 13:51:49 CST 2021, time=2021-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952235, encodeId=b6c7952235ed, content=认真, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Tue Mar 30 08:18:03 CST 2021, time=2021-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952183, encodeId=af0595218382, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Mar 29 23:01:49 CST 2021, time=2021-03-29, status=1, ipAttribution=)]
    2021-03-29 医鸣惊人

    认真学习了

    0

相关资讯

J Clin Oncol:依维替尼联合阿扎胞苷治疗新确诊的急性髓系白血病

Ivosidenib(依维替尼)是突变型异柠檬酸脱氢酶1(IDH1)的一种口服抑制剂,已获批用于治疗IDH1突变型(mIDH1)急性髓细胞性白血病(AML)。既往研究表明,将阿扎胞苷加入依维替尼可增强

NEJM:Venetoclax治疗急性髓性白血病(AML),III期临床取得正面结果

相比于安慰剂联合阿扎胞苷,venetoclax联合阿扎胞苷可延长总体生存期(OS)。

NEJM:阿扎胞苷口服剂用于化疗缓解后老年急性髓系白血病患者的维持治疗

在诱导化疗后实现缓解的急性髓系白血病老年患者,接受阿扎胞苷口服剂 (CC-486)维持治疗可延长总体生存期和无复发生存期

J Clin Oncol:Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS

约20%的TP53突变型骨髓增生异常综合征(MDS)患者采用去甲基化药物治疗后可获得完全缓解(CR)。Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS的疗效如何呢?

J Clin Oncol:Eprenetapopt联合阿扎胞苷治疗TP53突变型MDS和AML

Eprenetapopt(APR-246)是一种新型的一类药物,可使p53蛋白重构,并重新激活其促凋亡和细胞周期阻滞的功能

TP53突变型骨髓增生异常综合症:Eprenetapopt未达到III期研究的主要终点

制药公司Aprea Therapeutics近日表示,一项针对TP53突变型骨髓增生异常综合症患者的III期研究未能达到其完全缓解(CR)率的主要终点。

拓展阅读

【Hemasphere】如何管理胚系DDX41突变患者

在血液恶性肿瘤患者中,对胚系DDX41突变的认识日益增加,导致北欧髓系肿瘤胚系易感性工作组提供了DDX41特异性诊断、监测和治疗建议,近日发表于《Hemasphere》,总结如下。

Blood:TP53基因突变及其等位基因状态对MDS伴del(5q)的影响

本研究对682例MDS-del(5q)患者的TP53异常进行了全面分析,检查了TP53突变及其等位基因状态对总生存期(OS)和AML转化的影响。结果近日发表于《Blood》。

【Leukemia】在大样本MDS中验证原始细胞计数的独立预后性能

《Leukemia》近日发表研究,作者通过在独立的患者队列中确定基于遗传的MLLclass是否优于IPSS-M,旨在评估MDS病例中原始细胞量化的必要性。

【柳叶刀血液学】低剂量来那度胺治疗非输血依赖低危del(5q) MDS的3期研究

学者开展了3期随机SintraREV研究,旨在评估低剂量来那度胺2年早期干预是否可以延缓非输血依赖的贫血del(5q) MDS患者的输血依赖。

【柳叶刀血液学】罗特西普对比ESA治疗未经ESA治疗的输血依赖较低危MDS的3期研究结果

该研究预先计划的中期分析显示,对于输血依赖、未经红细胞生成刺激剂治疗的较低危骨髓增生异常综合征(MDS)的患者的贫血,罗特西普比红细胞生成刺激剂epoetin alfa更有效。

【BJH】AML/MDS异基因移植后阿扎胞苷和干扰素α抢先治疗安全有效

上海市第一人民医院血液科开展了一项单臂前瞻性研究,纳入接受allo-HSCT后易复发的AML/MDS患者,旨在评估阿扎胞苷联合IFN-α的疗效和安全性,主要终点为开始治疗后的总缓解率。

成人骨髓增生异常综合征和急性髓系白血病国际共识分类与WHO第5版分类的比较

Institute of Hematology and Center for Hemato-Oncological research (CREO), University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy · 2023-01-05

2022 国际共识:骨髓增生异常综合征及其相关实体的分类

国外血液科相关专家小组 · 2022-10-26

2022 ASTCT指南:造血细胞移植治疗儿童急性髓性白血病和骨髓增生异常综合征

美国移植与细胞治疗学会(ASTCT,American Society for Transplantation and Cellular Therapy) · 2022-09-05

骨髓增生异常综合征伴原始细胞增多(MDS-EB)诊疗指南(2022年版)

中华人民共和国国家卫生健康委员会 · 2022-06-30

Baidu
map
Baidu
map
Baidu
map